
© 2011 by the American Society of Health-System Pharmacists, Inc.
Authors: Gerald K. McEvoy, Pharm.D.
AHFS DI® Essentials™ offers healthcare professionals easy access to knowledge that
is critical at the point of care. Essentials™ monographs draw on the meticulously evidence-based guidelines in the full AHFS DI® database, distilling essential information on prescription and key over-the-counter (OTC) drugs in an easy-to-use and highly structured outline format.

ACP PIER & AHFS DI® Essentials™
© 2010 ACP PIER: American College of Physicians / © 2011 AHFS DI® Essentials™
Authors/Editors: ACP PIER: American College of Physicians (ACP) © 2010 by the American College of Physicians
PIER© is a collection of over 490 evidence summaries published by the American College of Physicians (ACP). Each module contains twelve uniformly structured sections and provides authoritative guidance on over 5000 topics to improve the quality of care.
AHFS DI® Essentials™ by the American Society of Health-System Pharmacists® (ASHP) is designed to offer health professionals easy access to knowledge that is critical at the point of care. Essentials™ monographs draw on the meticulously evidence-based guidelines in the full AHFS DI® database, distilling for the health professional the essential information on prescription and key over-the-counter (OTC) drugs in an easy-to-use, highly structured outline format.
UPDATED MODULES:
Borderline Personality Disorder; Breast Cancer; Deep Venous Thrombosis; Drug Prescribing in the Older Patient; Pyelonephritis; Screening for Tuberculosis; Urinary Tract Infection.

© 2011 by the American College of Physicians
Authors/Editors: American College of Physicians (ACP)
Subjects: Internal Medicine, Point-of-care, EBM
A pre-appraised, evidence-based clinical tool that defines the standard of care, including value-added abstracts of original journal articles and drug treatment information.
What's new in the May 2011 ACP Journal Club?
- Therapeutics
- Clinical Prediction Guide: CHA2DS2-VASc had better discrimination than CHADS2 for predicting risk for thromboembolism in atrial fibrillation








